The course and correlates of high hospital utilization in sickle cell disease: Evidence from a large, urban Medicaid managed care organization

Christopher P Carroll, Haywood Carlton, Peter Fagan, Sophie Lanzkron

Research output: Contribution to journalArticle

Abstract

Although most patients with sickle cell disease (SCD) are hospitalized infrequently and manage painful crises at home, a small subpopulation is frequently admitted to emergency departments and inpatient units. This small group accounts for the majority of health care expenses for patients with SCD. Using inpatient claims data from a large, urban Medicaid MCO for 5 consecutive years, this study sought to describe the course of high inpatient utilization (averaging four or more admissions enrolled per year for at least 1 year) in members with a diagnosis of SCD and a history of hospitalizations for vaso-occlusive crisis. High utilizers were compared with the other members with SCD on demographics, medical and psychiatric comorbidity, and use of other health care resources. Members who were high utilizers had more diagnostic mentions of sickle cell complications than low utilizers. However, the pattern of high inpatient utilization was likely to moderate over successive years, and return to the pattern after moderation was uncommon. Despite this, a small subpopulation engaged in exceptional levels of inpatient utilization over multiple years.

Original languageEnglish (US)
Pages (from-to)666-670
Number of pages5
JournalAmerican Journal of Hematology
Volume84
Issue number10
DOIs
StatePublished - Oct 2009

Fingerprint

Medicaid
Managed Care Programs
Sickle Cell Anemia
Inpatients
Organizations
Delivery of Health Care
Health Resources
Psychiatry
Hospital Emergency Service
Comorbidity
Hospitalization
Demography

ASJC Scopus subject areas

  • Hematology

Cite this

@article{77b3a639d85d4c9eb74dbb0545c30fd0,
title = "The course and correlates of high hospital utilization in sickle cell disease: Evidence from a large, urban Medicaid managed care organization",
abstract = "Although most patients with sickle cell disease (SCD) are hospitalized infrequently and manage painful crises at home, a small subpopulation is frequently admitted to emergency departments and inpatient units. This small group accounts for the majority of health care expenses for patients with SCD. Using inpatient claims data from a large, urban Medicaid MCO for 5 consecutive years, this study sought to describe the course of high inpatient utilization (averaging four or more admissions enrolled per year for at least 1 year) in members with a diagnosis of SCD and a history of hospitalizations for vaso-occlusive crisis. High utilizers were compared with the other members with SCD on demographics, medical and psychiatric comorbidity, and use of other health care resources. Members who were high utilizers had more diagnostic mentions of sickle cell complications than low utilizers. However, the pattern of high inpatient utilization was likely to moderate over successive years, and return to the pattern after moderation was uncommon. Despite this, a small subpopulation engaged in exceptional levels of inpatient utilization over multiple years.",
author = "Carroll, {Christopher P} and Haywood Carlton and Peter Fagan and Sophie Lanzkron",
year = "2009",
month = "10",
doi = "10.1002/ajh.21515",
language = "English (US)",
volume = "84",
pages = "666--670",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "10",

}

TY - JOUR

T1 - The course and correlates of high hospital utilization in sickle cell disease

T2 - Evidence from a large, urban Medicaid managed care organization

AU - Carroll, Christopher P

AU - Carlton, Haywood

AU - Fagan, Peter

AU - Lanzkron, Sophie

PY - 2009/10

Y1 - 2009/10

N2 - Although most patients with sickle cell disease (SCD) are hospitalized infrequently and manage painful crises at home, a small subpopulation is frequently admitted to emergency departments and inpatient units. This small group accounts for the majority of health care expenses for patients with SCD. Using inpatient claims data from a large, urban Medicaid MCO for 5 consecutive years, this study sought to describe the course of high inpatient utilization (averaging four or more admissions enrolled per year for at least 1 year) in members with a diagnosis of SCD and a history of hospitalizations for vaso-occlusive crisis. High utilizers were compared with the other members with SCD on demographics, medical and psychiatric comorbidity, and use of other health care resources. Members who were high utilizers had more diagnostic mentions of sickle cell complications than low utilizers. However, the pattern of high inpatient utilization was likely to moderate over successive years, and return to the pattern after moderation was uncommon. Despite this, a small subpopulation engaged in exceptional levels of inpatient utilization over multiple years.

AB - Although most patients with sickle cell disease (SCD) are hospitalized infrequently and manage painful crises at home, a small subpopulation is frequently admitted to emergency departments and inpatient units. This small group accounts for the majority of health care expenses for patients with SCD. Using inpatient claims data from a large, urban Medicaid MCO for 5 consecutive years, this study sought to describe the course of high inpatient utilization (averaging four or more admissions enrolled per year for at least 1 year) in members with a diagnosis of SCD and a history of hospitalizations for vaso-occlusive crisis. High utilizers were compared with the other members with SCD on demographics, medical and psychiatric comorbidity, and use of other health care resources. Members who were high utilizers had more diagnostic mentions of sickle cell complications than low utilizers. However, the pattern of high inpatient utilization was likely to moderate over successive years, and return to the pattern after moderation was uncommon. Despite this, a small subpopulation engaged in exceptional levels of inpatient utilization over multiple years.

UR - http://www.scopus.com/inward/record.url?scp=70349492889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349492889&partnerID=8YFLogxK

U2 - 10.1002/ajh.21515

DO - 10.1002/ajh.21515

M3 - Article

C2 - 19743465

AN - SCOPUS:70349492889

VL - 84

SP - 666

EP - 670

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 10

ER -